Detalhe da pesquisa
1.
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancer.
J Pathol;
262(1): 105-120, 2024 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37850574
2.
Paracrine Wnt signaling is necessary for prostate epithelial proliferation.
Prostate;
82(5): 517-530, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35014711
3.
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer.
Br J Cancer;
124(2): 383-390, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33012782
4.
Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response.
Br J Cancer;
125(12): 1666-1676, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34663950
5.
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL.
Hematol Oncol;
37(4): 352-359, 2019 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31385336
6.
Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer.
Prostate;
76(9): 810-22, 2016 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26990456
7.
Molecular Pathology of Prostate Cancer.
Clin Lab Med;
44(2): 161-180, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38821639
8.
Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted Therapies.
bioRxiv;
2024 Apr 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38645034
9.
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates.
NPJ Precis Oncol;
8(1): 104, 2024 May 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38760413
10.
Androgen-regulated stromal complement component 7 (C7) suppresses prostate cancer growth.
Oncogene;
42(32): 2428-2438, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37400528
11.
Metastatic Bladder Cancer Expression and Subcellular Localization of Nectin-4 and Trop-2 in Variant Histology: A Rapid Autopsy Study.
Clin Genitourin Cancer;
21(6): 669-678, 2023 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37344281
12.
A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer.
Clin Genitourin Cancer;
21(2): 265-272, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36710146
13.
Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer.
JCI Insight;
8(7)2023 04 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36821396
14.
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.
Nat Commun;
14(1): 2041, 2023 04 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37041154
15.
Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models.
J Clin Invest;
133(22)2023 11 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37725435
16.
ASSESSMENT OF CELL SURFACE TARGETS IN METASTATIC PROSTATE CANCER: EXPRESSION LANDSCAPE AND MOLECULAR CORRELATES.
Res Sq;
2023 Dec 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38196594
17.
Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res;
28(14): 3127-3140, 2022 07 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35552660
18.
Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity.
Nat Commun;
13(1): 6828, 2022 11 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36369237
19.
Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterations.
Cancer Res Commun;
2(5): 277-285, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36337169
20.
Molecular Pathology of Prostate Cancer.
Surg Pathol Clin;
14(3): 387-401, 2021 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34373091